Follow-The-Filings

ASND Ascendis Pharma A/S

Ascendis Pharma A/S earnings company data as of 4:48 AM ET 10/4

Scheduled

2 periods · newest first · EPS & Rev stacked · nothing reported yet

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS 1.13 — —
Rev — — —
FY2026 Q2 13 Aug EPS 0.78 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 rows shown

Filed Form Detail Links
4 Period Apr 14, 2026
4 Period Sep 8, 2026
4 Period Sep 2, 2026
4 Period Aug 14, 2026
4 Period Jun 2, 2026

4 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice